The Technische Universität Berlin, known as TU Berlin for short and unofficially as the Technical University of Berlin or Berlin Institute of Technology, is a research university located in Berlin, Germany and one of the largest and most prestigious research and education institutions in Germany. The university was founded in 1879. It has the highest proportion of foreign students out of universities in Germany, with 20.9% in the summer semester of 2007, roughly 5,598 students. The university alumni and professor list include National Academies elections, two National Medal of Science laureates and ten Nobel Prize winners.The TU Berlin is a member of TU9, an incorporated society of the largest and most notable German institutes of technology and of the Top Industrial Managers for Europe network, which allows for student exchanges between leading European engineering schools. It also belongs to the Conference of European Schools for Advanced Engineering Education and Research. As of 2013, TU Berlin is ranked 41st in the world in the field of Engineering & Technology and 1st in Germany in Mathematics according to QS World University Rankings.The university is known for its high ranked engineering programmes, especially in mechanical engineering and engineering management. Wikipedia.
PubMed | Biosyntia and TU Berlin
Type: Journal Article | Journal: Microbial biotechnology | Year: 2016
Biology is an analytical and informational science that is becoming increasingly dependent on chemical synthesis. One example is the high-throughput and low-cost synthesis of DNA, which is a foundation for the research field of synthetic biology (SB). The aim of SB is to provide biotechnological solutions to health, energy and environmental issues as well as unsustainable manufacturing processes in the frame of naturally existing chemical building blocks. Xenobiology (XB) goes a step further by implementing non-natural building blocks in living cells. In this context, genetic code engineering respectively enables the re-design of genes/genomes and proteins/proteomes with non-canonical nucleic (XNAs) and amino (ncAAs) acids. Besides studying information flow and evolutionary innovation in living systems, XB allows the development of new-to-nature therapeutic proteins/peptides, new biocatalysts for potential applications in synthetic organic chemistry and biocontainment strategies for enhanced biosafety. In this perspective, we provide a brief history and evolution of the genetic code in the context of XB. We then discuss the latest efforts and challenges ahead for engineering the genetic code with focus on substitutions and additions of ncAAs as well as standard amino acid reductions. Finally, we present a roadmap for the directed evolution of artificial microbes for emancipating rare sense codons that could be used to introduce novel building blocks. The development of such xenomicroorganisms endowed with a genetic firewall will also allow to study and understand the relation between code evolution and horizontal gene transfer.